Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
 

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-23-314 (UH3 Clinical Trials Not Allowed) UH3 10/15/2026 Sudhir Srivastava, Ph.D., M.P.H.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/15/2026 Sudhir Srivastava, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 01/08/2026 Sharon Ross, Ph.D., M.P.H.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes PAR-22-131 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025 Richard Mazurchuk, Ph.D.
Biology of Bladder Cancer PAR-22-218 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025
Biology of Bladder Cancer PAR-22-219 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 09/08/2025
NCI Clinical and Translational Exploratory/Developmental Studies PAR-22-216 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 07/02/2025 Marjorie Perloff, M.D.
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 07/02/2025 Matthew Young, Ph.D.
Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials NOT-CA-23-071 07/01/2025 Ellen Richmond, M.S., G.N.P.-B.C.
HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery NOT-NS-22-095 06/25/2025 Rachel Altshuler, Ph.D.